New drug for Huntington’s Disease

Federal regulators approved the first treatment for Huntington’s disease in the U.S. Huntington's, is a rare disease that causes uncontrolled movements, deterioration of mental abilities and, ultimately, death. The disease is inherited. The new medication called, Xenazine, is not a cure, and has some potentially serious side effects. The full text of this article may be found on the Newsday website among others.